Gainers

• Picard Medical (AMEX:PMI) shares moved upwards by 34.6% to $4.32 during Monday's pre-market session. The company's market cap stands at $6.5 million. As per the press release, Q2 earnings came out 3 days ago.
• Cypherpunk Technologies (NASDAQ:CYPH) stock moved upwards by 23.94% to $1.76. The market value of their outstanding shares is at $153.0 million.
• Stablecoin Development (AMEX:SDEV) stock rose 10.52% to $1.26. The market value of their outstanding shares is at $30.9 million.
• Quanterix (NASDAQ:QTRX) stock moved upwards by 8.36% to $3.24. The market value of their outstanding shares is at $141.4 million.
• Innovative Eyewear (NASDAQ:LUCY) stock rose 8.2% to $0.74. The company's market cap stands at $5.8 million.
• Aethlon Medical (NASDAQ:AEMD) shares increased by 8.05% to $2.95. The company's market cap stands at $1.9 million.

Losers

• Regenxbio (NASDAQ:RGNX) shares fell 24.0% to $8.15 during Monday's pre-market session. The company's market cap stands at $707.6 million.
• ZeroStack (NASDAQ:ZSTK) shares declined by 16.99% to $3.91. The company's market cap stands at $11.3 million.
• Jupiter Neurosciences (NASDAQ:JUNS) stock declined by 13.71% to $5.35. The company's market cap stands at $4.7 million.
• Kairos Pharma (AMEX:KAPA) shares declined by 12.69% to $0.25. The company's market cap stands at $6.8 million.
• Eloxx Pharma (NASDAQ:ELOX) stock decreased by 12.28% to $18.4. The company's market cap stands at $72.0 million.
• Radiopharm Theranostics (NASDAQ:RADX) stock declined by 9.84% to $2.2. The market value of their outstanding shares is at $18.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.